| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1B SZT2 SPEG LRRK1 TTC3 ZNF865 ADGRA2 MTOR SGSM2 NBEAL2 A4GALT MTMR3 TNK2 TTC38 TEX19 RIC1 HR | 1.97e-08 | 1105 | 101 | 17 | 35748872 |
| Pubmed | SETD1B NCKAP1 WDR7 SPEG OBSL1 SACM1L EPG5 ARFGEF3 SGSM2 MTMR3 | 3.22e-07 | 407 | 101 | 10 | 12693553 | |
| Pubmed | Hepatitis C virus upregulates Beclin1 for induction of autophagy and activates mTOR signaling. | 8.35e-06 | 2 | 101 | 2 | 22674982 | |
| Pubmed | Histone demethylase KDM5A regulates the ZMYND8-NuRD chromatin remodeler to promote DNA repair. | 8.35e-06 | 2 | 101 | 2 | 28572115 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 34309113 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 33351847 | ||
| Pubmed | Mice deficient in Epg5 exhibit selective neuronal vulnerability to degeneration. | 8.35e-06 | 2 | 101 | 2 | 23479740 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 38130221 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17664276 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 38223571 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 10652228 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 37115089 | ||
| Pubmed | 1.43e-05 | 105 | 101 | 5 | 9628581 | ||
| Pubmed | BCAS2 EI24 TUBGCP4 GEM SACM1L ARFGEF3 PTPN1 NBAS FAM120A AARS2 MTOR ASNS PRMT1 RARS2 ZC3HAV1 | 1.76e-05 | 1440 | 101 | 15 | 30833792 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 31047942 | ||
| Pubmed | Expression and clinical significances of Beclin1, LC3 and mTOR in colorectal cancer. | 2.50e-05 | 3 | 101 | 2 | 26097572 | |
| Pubmed | Enterococcus faecalis lipoteichoic acid regulates macrophages autophagy via PI3K/Akt/mTOR pathway. | 2.50e-05 | 3 | 101 | 2 | 29551680 | |
| Pubmed | DDiT4L promotes autophagy and inhibits pathological cardiac hypertrophy in response to stress. | 2.50e-05 | 3 | 101 | 2 | 28246202 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 32958058 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 24948418 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 32162707 | ||
| Pubmed | PRMT1 orchestrates with SAMTOR to govern mTORC1 methionine sensing via Arg-methylation of NPRL2. | 2.50e-05 | 3 | 101 | 2 | 38006878 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 33741434 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 31427543 | ||
| Pubmed | CD5 instructs extrathymic regulatory T cell development in response to self and tolerizing antigens. | 2.50e-05 | 3 | 101 | 2 | 25786177 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 3.98e-05 | 704 | 101 | 10 | 29955894 | |
| Pubmed | miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1. | 4.99e-05 | 4 | 101 | 2 | 22248718 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 28776671 | ||
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 6.86e-05 | 468 | 101 | 8 | 31056421 | |
| Pubmed | 7.92e-05 | 150 | 101 | 5 | 32423001 | ||
| Pubmed | The PtdIns3-phosphatase MTMR3 interacts with mTORC1 and suppresses its activity. | 8.30e-05 | 5 | 101 | 2 | 26787466 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 29321306 | ||
| Pubmed | 1.14e-04 | 504 | 101 | 8 | 34432599 | ||
| Pubmed | 1.19e-04 | 650 | 101 | 9 | 38777146 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SPCS2 DUSP14 OBSL1 PTPN1 FAM120A MTOR ASNS MTMR3 NID1 PRMT1 ZC3HAV1 | 1.26e-04 | 974 | 101 | 11 | 28675297 |
| Pubmed | TFEB-dependent induction of thermogenesis by the hepatocyte SLC2A inhibitor trehalose. | 1.74e-04 | 7 | 101 | 2 | 29996716 | |
| Pubmed | The deubiquitinase USP11 is a versatile and conserved regulator of autophagy. | 1.74e-04 | 7 | 101 | 2 | 34600886 | |
| Pubmed | 1.74e-04 | 7 | 101 | 2 | 26025256 | ||
| Pubmed | 1.78e-04 | 686 | 101 | 9 | 28380382 | ||
| Pubmed | 1.90e-04 | 285 | 101 | 6 | 34369648 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ENTPD7 LRRC8C GALNT10 CCPG1 SPCS2 EI24 LRP1B SACM1L A4GALT NID1 PRMT1 TWSG1 | 1.92e-04 | 1201 | 101 | 12 | 35696571 |
| Pubmed | 2.31e-04 | 8 | 101 | 2 | 17000758 | ||
| Pubmed | 2.38e-04 | 103 | 101 | 4 | 10574462 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NCKAP1 TTC3 SACM1L PHF2 MRM3 PTPN1 PBRM1 FAM120A MTOR ASNS PRMT1 PNPLA8 ZC3HAV1 | 2.49e-04 | 1425 | 101 | 13 | 30948266 |
| Pubmed | 2.58e-04 | 568 | 101 | 8 | 37774976 | ||
| Pubmed | Identification of APBB1 as a substrate for anaplastic lymphoma kinase. | 2.89e-04 | 44 | 101 | 3 | 39115278 | |
| Pubmed | CCPG1 BCAS2 OBSL1 TTC3 PTPN1 NBAS FAM120A ARHGEF10 MAP4K5 ASNS PNPLA8 FERMT2 ZC3HAV1 | 3.74e-04 | 1487 | 101 | 13 | 33957083 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | OBSL1 TTC3 NDUFS5 ARFGEF3 MRM3 PTPN1 NBAS FAM120A AARS2 MTMR3 RARS2 PNPLA8 ZC3HAV1 | 3.96e-04 | 1496 | 101 | 13 | 32877691 |
| Pubmed | 3.97e-04 | 49 | 101 | 3 | 34368113 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 4.10e-04 | 462 | 101 | 7 | 31138677 | |
| Pubmed | Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease. | 4.51e-04 | 11 | 101 | 2 | 32093570 | |
| Pubmed | 4.74e-04 | 52 | 101 | 3 | 20114047 | ||
| Pubmed | De novo genic mutations among a Chinese autism spectrum disorder cohort. | 5.41e-04 | 12 | 101 | 2 | 27824329 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 6.32e-04 | 497 | 101 | 7 | 36774506 | |
| Pubmed | mTORC1 phosphorylates UVRAG to negatively regulate autophagosome and endosome maturation. | 6.38e-04 | 13 | 101 | 2 | 25533187 | |
| Pubmed | 7.43e-04 | 14 | 101 | 2 | 15779907 | ||
| Pubmed | 7.43e-04 | 14 | 101 | 2 | 31806350 | ||
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 8.09e-04 | 375 | 101 | 6 | 32788342 | |
| Pubmed | 8.55e-04 | 15 | 101 | 2 | 19762545 | ||
| Pubmed | 9.09e-04 | 529 | 101 | 7 | 14621295 | ||
| Pubmed | 9.76e-04 | 16 | 101 | 2 | 28199315 | ||
| Pubmed | EVA1A/TMEM166 Regulates Embryonic Neurogenesis by Autophagy. | 1.10e-03 | 17 | 101 | 2 | 26905199 | |
| Pubmed | Mapping of five subtype genes for muscarinic acetylcholine receptor to mouse chromosomes. | 1.10e-03 | 17 | 101 | 2 | 10549128 | |
| Pubmed | 1.16e-03 | 157 | 101 | 4 | 30186101 | ||
| Pubmed | 1.18e-03 | 71 | 101 | 3 | 33541421 | ||
| Pubmed | The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer. | 1.18e-03 | 71 | 101 | 3 | 29346117 | |
| Pubmed | Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid. | 1.24e-03 | 18 | 101 | 2 | 16199891 | |
| Pubmed | Changes in thyroid status during perinatal development of MCT8-deficient male mice. | 1.24e-03 | 18 | 101 | 2 | 23696569 | |
| Pubmed | Integrin-linked kinase is an adaptor with essential functions during mouse development. | 1.24e-03 | 18 | 101 | 2 | 19829382 | |
| Pubmed | KDM5A ZMYND8 OBSL1 TTC3 LRP1B FAM120A ARHGEF10 SGSM2 USP32 MTMR3 BECN1 | 1.28e-03 | 1285 | 101 | 11 | 35914814 | |
| Pubmed | NCKAP1 KDM5A BCAS2 ZMYND8 NDUFS5 PHF2 MED24 MRM3 PBRM1 PRMT1 FHIP1A ZC3HAV1 | 1.34e-03 | 1497 | 101 | 12 | 31527615 | |
| Pubmed | 1.38e-03 | 75 | 101 | 3 | 25593309 | ||
| Pubmed | BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A. | 1.43e-03 | 419 | 101 | 6 | 33001583 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 1.45e-03 | 420 | 101 | 6 | 28065597 | |
| Pubmed | 1.49e-03 | 285 | 101 | 5 | 32838362 | ||
| Pubmed | KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1. | 1.53e-03 | 20 | 101 | 2 | 28199306 | |
| Pubmed | Identification of Protor as a novel Rictor-binding component of mTOR complex-2. | 1.53e-03 | 20 | 101 | 2 | 17461779 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.63e-03 | 430 | 101 | 6 | 35044719 | |
| Pubmed | 1.66e-03 | 80 | 101 | 3 | 16094384 | ||
| Pubmed | Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC. | 1.68e-03 | 293 | 101 | 5 | 31741433 | |
| Pubmed | 1.69e-03 | 21 | 101 | 2 | 19015235 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 1.71e-03 | 942 | 101 | 9 | 31073040 | |
| Pubmed | 1.77e-03 | 176 | 101 | 4 | 28692057 | ||
| Pubmed | 1.86e-03 | 300 | 101 | 5 | 10591208 | ||
| Pubmed | 1.95e-03 | 777 | 101 | 8 | 35844135 | ||
| Pubmed | 1.98e-03 | 606 | 101 | 7 | 36538041 | ||
| Pubmed | 2.03e-03 | 23 | 101 | 2 | 31748650 | ||
| Pubmed | 2.11e-03 | 87 | 101 | 3 | 33711283 | ||
| Pubmed | 2.21e-03 | 24 | 101 | 2 | 24347629 | ||
| Pubmed | 2.21e-03 | 24 | 101 | 2 | 19680556 | ||
| Pubmed | 2.48e-03 | 808 | 101 | 8 | 20412781 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.67e-03 | 475 | 101 | 6 | 31040226 | |
| Pubmed | SEMA3G TTC3 TIA1 AARS2 ARHGEF10 MAP4K5 NID1 PRMT1 TNK2 ITPRIPL1 | 2.83e-03 | 1215 | 101 | 10 | 15146197 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 4.93e-04 | 9 | 68 | 2 | 1230 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ENTPD7 GALNT10 CCPG1 STARD8 NBEAL1 SPEG MCF2 SEMA3G ADGRA2 GEM SACM1L ARFGEF3 FAM120A MED12L NID1 FERMT2 ZC3HAV1 | 2.76e-08 | 854 | 101 | 17 | M1533 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ENTPD7 GALNT10 CCPG1 STARD8 NBEAL1 SPEG MCF2 SEMA3G ADGRA2 GEM SACM1L ARFGEF3 FAM120A MED12L NID1 FERMT2 ZC3HAV1 | 4.86e-08 | 888 | 101 | 17 | MM1018 |
| Coexpression | GSE27786_CD4_TCELL_VS_NKTCELL_DN | 1.10e-06 | 200 | 101 | 8 | M4825 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_MEGAKARYOCYTE | LCA5 NCKAP1 ZMYND8 TUBGCP4 SACM1L P2RY1 MAP4K5 NBEAL2 MED12L NID1 TWSG1 | 7.59e-05 | 694 | 101 | 11 | M45731 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN | 7.81e-05 | 183 | 101 | 6 | M8886 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP | 1.08e-04 | 194 | 101 | 6 | M5852 | |
| Coexpression | GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP | 1.11e-04 | 195 | 101 | 6 | M5878 | |
| Coexpression | GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN | 1.20e-04 | 198 | 101 | 6 | M6841 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN | 1.22e-04 | 384 | 101 | 8 | M12527 | |
| Coexpression | GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 1.24e-04 | 199 | 101 | 6 | M8381 | |
| Coexpression | GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN | 1.24e-04 | 199 | 101 | 6 | M8367 | |
| Coexpression | GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP | 1.27e-04 | 200 | 101 | 6 | M5831 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH2_UP | 1.27e-04 | 200 | 101 | 6 | M5566 | |
| Coexpression | GSE7852_TREG_VS_TCONV_FAT_UP | 1.27e-04 | 200 | 101 | 6 | M5733 | |
| Coexpression | GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN | 1.27e-04 | 200 | 101 | 6 | M3039 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.97e-07 | 182 | 101 | 7 | dfde2d9950f445c6c936ac828f7210de87bb45ec | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.97e-07 | 182 | 101 | 7 | 52274af3136d4fd4a495f5882618444661421f0f | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.62e-06 | 189 | 101 | 6 | 3b35022c0619df6db234613aa53a076899ca9562 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.62e-06 | 189 | 101 | 6 | 358ff514f1c8aa46067208ddf1b68396d789c130 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.21e-06 | 193 | 101 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.03e-06 | 198 | 101 | 6 | c65103828a4755fcf3c0776c60d8ada1f0ad5278 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 6.39e-06 | 200 | 101 | 6 | cbe667eda1af222467df8bfa157aa22df488f133 | |
| ToppCell | Myeloid-Myeloid-E_(Neutrophils)|Myeloid / shred on cell class and cell subclass (v4) | 2.36e-05 | 150 | 101 | 5 | 1bffb8d86b737ac43be902d9468041aef3542f1f | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 158 | 101 | 5 | 30cceb73cf5e24b692da84d33342fd3b1ad5efe5 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 158 | 101 | 5 | 47793463640f98ee5f680a1ee5786b453355fd57 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.21e-05 | 160 | 101 | 5 | 8374ae912337947b2cc8d17d5840f306361fe1ff | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 161 | 101 | 5 | e227f7b711475624cf80e77f235b1783d88d57b4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-05 | 161 | 101 | 5 | 4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 161 | 101 | 5 | 8280a029026c272cae9649b27575831b0dd4e242 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 164 | 101 | 5 | 0e424a69999eee13d27c4ff4f4ba3df64d3c2bda | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 164 | 101 | 5 | fe9ecdd7a6cbaf910f42654eba75f79bea740a00 | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 166 | 101 | 5 | 758817f38e843db4ef6ab3e2bfb9f1a2075c9af9 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 167 | 101 | 5 | f90cf0f29c14df4f211193326699e599ef955fa4 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-05 | 168 | 101 | 5 | 937332580a522826b820e0b09080013f19f58479 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-neutrophil-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-05 | 168 | 101 | 5 | b0376e3687fa85f091654196403eecedc219d0cd | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 171 | 101 | 5 | b3ea26d181f91ea07074f403e7dca9b6b671b1a2 | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 171 | 101 | 5 | d6ae456e88ec49a8609a5e5e3af9f51921e66744 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.54e-05 | 172 | 101 | 5 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 173 | 101 | 5 | 03cee3d24bc433e91a867ce951589de64a0538af | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.20e-05 | 177 | 101 | 5 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.63e-05 | 180 | 101 | 5 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.93e-05 | 182 | 101 | 5 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | facs|World / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 182 | 101 | 5 | 08f775135b451be709f5fc8e1cbcf63425794a2e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.93e-05 | 182 | 101 | 5 | d486b0213bd3cf20965cb4e38e95981c4aaff259 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.57e-05 | 186 | 101 | 5 | ad55da1dbb173721101126826b6db9d3434cb377 | |
| ToppCell | Thalamus-Endothelial|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.57e-05 | 186 | 101 | 5 | dcc6e4417c4123d5ca6b96fa8ca4874626aaebdb | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.74e-05 | 187 | 101 | 5 | e1b41560c26795a7d353b9468b1bb6fc7c6b379e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.74e-05 | 187 | 101 | 5 | 8ee3bf885897efd634c3a0567637142a9f55e693 | |
| ToppCell | Substantia_nigra-Endothelial|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.09e-05 | 189 | 101 | 5 | bef8234bd9c4d6e3cdef0791d8066b39ba56ebba | |
| ToppCell | Globus_pallidus-Endothelial|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.09e-05 | 189 | 101 | 5 | ad7dc9d25edd68fb624380a082c389fe7d640e7d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 189 | 101 | 5 | 6f0fc5271a7d3682f145e734abc3be6473dda2e2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 189 | 101 | 5 | 3b9ce8964b16cb2200d30cbb0bfc711dcad2380e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 189 | 101 | 5 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 190 | 101 | 5 | d85b34d19af43d83ebe728f3c7bbefd3792df4a6 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.45e-05 | 191 | 101 | 5 | 6c1283d51a845cff67ed5e500f7e944165297b53 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 191 | 101 | 5 | d35692c652977500a3c36aa26c347a072b71e441 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 191 | 101 | 5 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.45e-05 | 191 | 101 | 5 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 191 | 101 | 5 | 2a107e9096eb58b81b3da61547904d85754f6b2f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 191 | 101 | 5 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.64e-05 | 192 | 101 | 5 | 86d561c30554ff04c21801d4aaf8e3c9efe49af4 | |
| ToppCell | COVID-19_Severe-Myeloid_G-immature_Neutrophil|COVID-19_Severe / Disease group, lineage and cell class | 7.64e-05 | 192 | 101 | 5 | 303deb68da2e4a75e6ee5a79478182a8bc41c7c5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.64e-05 | 192 | 101 | 5 | 3ce486cd5171f2d04ac4f7f87bead8b0d8c99c17 | |
| ToppCell | Endothelial-Endothelial-B|Endothelial / shred on cell class and cell subclass (v4) | 7.64e-05 | 192 | 101 | 5 | f8d7bd81e031d09a557722627c2f6180811cc6ab | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-05 | 194 | 101 | 5 | 3cffb5c58f6d5bd254f39ee9c41b7e1e4da0ff75 | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 8.02e-05 | 194 | 101 | 5 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 8.02e-05 | 194 | 101 | 5 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.21e-05 | 195 | 101 | 5 | de23409b1b4146b8ae286850b829ec8dceed0117 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.21e-05 | 195 | 101 | 5 | fb3dc2c8fd125f23d0c3aa211520778aac8d6dda | |
| ToppCell | Posterior_cortex-Endothelial|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.21e-05 | 195 | 101 | 5 | 988e3449691cc228cb55e5e30355136c97b12262 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.41e-05 | 196 | 101 | 5 | c373465e34e2dd581247962d59e0477aae877079 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-05 | 196 | 101 | 5 | 9d18381d7aaa063094a5df769a04c73350471525 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-05 | 196 | 101 | 5 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-05 | 196 | 101 | 5 | ac4c8571bd792538f8df7b9bdd90ef58405fd3b1 | |
| ToppCell | critical-Epithelial-Secretory|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.41e-05 | 196 | 101 | 5 | 7da687eb983a54c28ee990424cc52e01caf5f4aa | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.41e-05 | 196 | 101 | 5 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.41e-05 | 196 | 101 | 5 | 47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.41e-05 | 196 | 101 | 5 | 8b5337ccf74de90e8b89a02ac00671af1de2cfff | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-05 | 196 | 101 | 5 | 70b2e0b4ff4f1bc03fb72ace07a8a44f4b415922 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-05 | 196 | 101 | 5 | a52cb512c6173be92aa9c4d96e2abbc32f45478d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-05 | 196 | 101 | 5 | afddacc0fb8b9c73dad5333137deb471a6ebdc06 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-05 | 197 | 101 | 5 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.62e-05 | 197 | 101 | 5 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.62e-05 | 197 | 101 | 5 | 01249bd485a3734de87ae6ed9c749597f39c6335 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.62e-05 | 197 | 101 | 5 | 8dd10962b6ba587512b2e68c762ade68c751cbc8 | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.62e-05 | 197 | 101 | 5 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.62e-05 | 197 | 101 | 5 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-05 | 198 | 101 | 5 | 82f6ac18c3a6487f03579b5c247844f1c115c2be | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.83e-05 | 198 | 101 | 5 | 637f11e292b90d86cdc0d0d828eb26f38289c25b | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-05 | 198 | 101 | 5 | f870e398e996c1f28c8462d87b18f71b20c71011 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-05 | 198 | 101 | 5 | 66d65951a6a39cc5d5ba5f96fdf3eb61c74ac616 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 9.04e-05 | 199 | 101 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.04e-05 | 199 | 101 | 5 | 7cbd98dd10c91584dee04593910031e90c1340b8 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.04e-05 | 199 | 101 | 5 | 5919933c4b842b98fc98685dc8c72c8dd32c6ea3 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.04e-05 | 199 | 101 | 5 | 0dde17381b8a95bfddb4d1052b13d33f37b05d13 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.04e-05 | 199 | 101 | 5 | 20f760d92c351a1dac4cc0a424c443ea03a179fe | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 9.04e-05 | 199 | 101 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.04e-05 | 199 | 101 | 5 | a1635a52318be0423f8e4fc03d971c28cd22b57e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.04e-05 | 199 | 101 | 5 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.04e-05 | 199 | 101 | 5 | caf2e050b21e7a16ce4e51b3f135debd06810231 | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.25e-05 | 200 | 101 | 5 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.25e-05 | 200 | 101 | 5 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.25e-05 | 200 | 101 | 5 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | distal-mesenchymal-Pericyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.25e-05 | 200 | 101 | 5 | fe31287cfb51d45643bdedbaa5efc03ed87263c6 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-ILC|IIF / Disease, condition lineage and cell class | 9.25e-05 | 200 | 101 | 5 | edb0b252e6ff9824908d1ff7d0d42710b00949c8 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.25e-05 | 200 | 101 | 5 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | distal-mesenchymal-Pericyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.25e-05 | 200 | 101 | 5 | 867935701fac71a3fe01578362da0676f959736c | |
| ToppCell | severe-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.25e-05 | 200 | 101 | 5 | 5ee43386da8261d2e7602a152e6ba4338d844e08 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.25e-05 | 200 | 101 | 5 | f9bc22ff17bb1c751e6b05bca3f403836f33459a | |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.25e-05 | 200 | 101 | 5 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| ToppCell | proximal-mesenchymal-Pericyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.25e-05 | 200 | 101 | 5 | 03119a979bc912a98e6fc87addcbc25d8ecf2fb0 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.25e-05 | 200 | 101 | 5 | 0a7640db28c708003d5da2d19eb651f6fedfd710 | |
| ToppCell | proximal-mesenchymal-Pericyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.25e-05 | 200 | 101 | 5 | a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b | |
| ToppCell | severe-unassigned|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.06e-04 | 128 | 101 | 4 | bef9cf0078fa8498d63f0723f1fa4a3c92405e10 | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.88e-06 | 187 | 101 | 8 | 3943_UP | |
| Disease | Immunologic Deficiency Syndromes | 6.18e-05 | 23 | 99 | 3 | C0021051 | |
| Disease | coagulation factor IXAB measurement | 1.11e-04 | 5 | 99 | 2 | EFO_0020264 | |
| Disease | AP-4 complex subunit mu-1 measurement | 1.11e-04 | 5 | 99 | 2 | EFO_0801385 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 1.54e-04 | 31 | 99 | 3 | C1335167 | |
| Disease | factor VII activating protease measurement | 8.47e-04 | 55 | 99 | 3 | EFO_0009368 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 8.48e-04 | 13 | 99 | 2 | EFO_0800474 | |
| Disease | YKL40 measurement | 1.14e-03 | 15 | 99 | 2 | EFO_0004869 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.30e-03 | 16 | 99 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Antibody Deficiency Syndrome | 1.47e-03 | 17 | 99 | 2 | C0003257 | |
| Disease | X-21441 measurement | 1.47e-03 | 17 | 99 | 2 | EFO_0800814 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 1.84e-03 | 19 | 99 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 1.84e-03 | 19 | 99 | 2 | DOID:4928 (is_marker_for) | |
| Disease | unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 2.16e-03 | 76 | 99 | 3 | EFO_0003761, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | progression free survival, ovarian serous carcinoma | 2.46e-03 | 22 | 99 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | triacylglycerol 54:6 measurement | 2.46e-03 | 22 | 99 | 2 | EFO_0010424 | |
| Disease | Colorectal Carcinoma | 2.53e-03 | 702 | 99 | 8 | C0009402 | |
| Disease | carotid plaque build | 2.87e-03 | 84 | 99 | 3 | EFO_0006501 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.93e-03 | 24 | 99 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | feeling nervous measurement | 3.17e-03 | 87 | 99 | 3 | EFO_0009597 | |
| Disease | coffee consumption measurement | 3.34e-03 | 182 | 99 | 4 | EFO_0006781 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ESMGASKYRWFHNAC | 186 | Q9GZX9 | |
| WLCYNGEIYNHKKMQ | 71 | P08243 | |
| DILMPFNLFCKHWTY | 1806 | Q9HCE0 | |
| KLALEEENHMGWFCV | 851 | O15013 | |
| AMHGEIFCYLAKYWL | 71 | Q8WWZ4 | |
| ALCMRDFVDHYNGWI | 231 | Q9NPC4 | |
| HFLYLAMWACGALAV | 1026 | Q96PE1 | |
| IMNYDEFQHCWSKFV | 151 | Q9HC16 | |
| WKEHEAFYSSALCMV | 391 | Q96NS5 | |
| GQLEVYLKDGWHMVC | 46 | P06127 | |
| LMKFHNVCLLEAYNW | 126 | O95147 | |
| YNVMVQCWAHKPEDR | 361 | Q07912 | |
| WENVYGFDMSCIKDV | 216 | Q99873 | |
| HENMALYWKDCYEAL | 1706 | Q6ZS30 | |
| YLLHIFMEAGCLDWC | 1266 | Q4ADV7 | |
| WLHDHCMQVGDAYLI | 141 | P55040 | |
| FVNLMAYDFHGSWEK | 206 | Q13231 | |
| WVNEGKHAKFRCYVM | 256 | O75147 | |
| YFNKTDWIFGDAMCK | 111 | P47900 | |
| VYDVKDCGMNFEWNL | 246 | Q5JU00 | |
| HALSYWKPFLVNMCV | 401 | P18031 | |
| LHYNDMWLKVGDCVF | 1151 | Q86U86 | |
| HTLDFIYNEDMICWI | 236 | Q9NZR2 | |
| FQEGMLEKHEYLTWI | 241 | Q86YW9 | |
| QCFKSAWMYQVLHEG | 476 | Q9NQZ7 | |
| VWCLDDKANSLVMYH | 1751 | Q38SD2 | |
| YDCHSMKGNQLWKYR | 536 | Q86SR1 | |
| HWLMVVAEFLSLGCY | 1066 | O43861 | |
| KTLCMDAVQHWGKQY | 566 | O43451 | |
| KERTQEKWGFPMCHY | 426 | Q8N6Q8 | |
| WDNKFDHAMVAFLDC | 361 | Q14457 | |
| PDCHLLYAQMDWAVF | 1161 | O43593 | |
| QHYHMKTLGWCDVGY | 81 | O75594 | |
| IGLAFDCVDKMVYWT | 981 | P14543 | |
| IMCYENKWEEPGHLT | 351 | Q86VQ0 | |
| LAVCHGVMYKQLSAW | 176 | Q9UGJ1 | |
| LYNFNWDHCGKMEPT | 81 | P41439 | |
| WNHMLGYLAALAKAC | 71 | Q9NZB2 | |
| AYQWMVPFLHRCEKQ | 931 | A2RRP1 | |
| RMCDYKHHWQDSFVG | 196 | Q5VZY2 | |
| SGFMLQCELCKDWFH | 1171 | P29375 | |
| DAMEKWIIFGFILCH | 256 | Q9Y2A7 | |
| VYMCDLHTKIPFINW | 66 | Q04941 | |
| MGNAWALVAHKYDFK | 326 | Q6GPH6 | |
| QRYMLKELDTFCHWN | 661 | Q9ULG6 | |
| EEGLDLHYWKHCLML | 766 | O60308 | |
| NQERDYILWSKCMHD | 456 | Q05DH4 | |
| MEFKGNYWHETCFVC | 116 | Q5TD97 | |
| CFEYRWFNKGIEMHQ | 216 | O14681 | |
| YWDMASANFKHAIGL | 1521 | Q5TH69 | |
| HCWQLKAMDGYFNLT | 141 | P51993 | |
| SYSFKHCWKMDEVGI | 751 | P10911 | |
| MDLKLKDCEFWYSLH | 1 | Q6PJQ5 | |
| LRCDNEKQYAHWMAA | 456 | Q96AC1 | |
| EKQYAHWMAACRLAS | 461 | Q96AC1 | |
| MYGCTEAFLADAKWI | 206 | Q9ULU4 | |
| MIFDCEGLGLKHFWK | 151 | Q9UDX4 | |
| MHSCSINGKYFDWIL | 196 | Q9NTJ5 | |
| KCQHEMDQYWGIGSL | 161 | P07358 | |
| QTLKLLLCYHGWMFE | 126 | Q92523 | |
| VCLQDSVLAFWKHGM | 776 | Q9Y4K4 | |
| EMEWLDFGHKFADRC | 446 | Q13615 | |
| YWACHGGHKDIVEML | 111 | Q92882 | |
| AMKHFGELEIQATWY | 1436 | P42345 | |
| SHYLGGCQYKMWQAI | 591 | Q9NP80 | |
| LKIMGYDWAERCQHV | 361 | Q5T160 | |
| WMEPRYKEAANHCAL | 1281 | Q5T011 | |
| CHELLVDMIYFWKNE | 271 | Q9UGI8 | |
| FETACWYMGKHLLEA | 366 | O75151 | |
| GWVCDQRVMKFHKYE | 306 | Q9HC36 | |
| AKSHDLMSGFWNACY | 1731 | Q6ZNJ1 | |
| PYKMAGRCHAFEKEW | 26 | O43920 | |
| LHMGGVYWFCNNLIK | 736 | O75448 | |
| DVMCSYVWEHLDVGY | 821 | O43147 | |
| YVWEHLDVGYVQGMC | 826 | O43147 | |
| FCKSHIHDWGLFAME | 1831 | Q9UPS6 | |
| QDHFWDGKGCEMICY | 56 | O75711 | |
| GCNAWKVYNENLVHM | 131 | O75934 | |
| QCFKKHWLAVFGLVM | 626 | Q5T5J6 | |
| GKECQCKRWHDMEVY | 201 | Q9NX31 | |
| CKRWHDMEVYSFSGL | 206 | Q9NX31 | |
| FWVTQLRACAKYHME | 161 | Q9BXB5 | |
| WYNKVFGHLCAMEVA | 991 | Q92502 | |
| GEYFKEEACNMAWEL | 141 | Q5JTZ9 | |
| FNWSMYSQHACLIEG | 121 | P11086 | |
| WCVYFQSEGALMLAH | 91 | Q6ZRR5 | |
| ACGKTFGFIENLMWH | 701 | P0CJ78 | |
| YWNLVSLGLCHFDMN | 41 | Q9HCG1 | |
| LMDHWRGYKGKDLCQ | 371 | Q9NU63 | |
| DCLAHPWLQDAYLMK | 3211 | Q15772 | |
| SCFFAIVALIWDYMH | 91 | Q15005 | |
| DCVKESGSHMWIYVF | 161 | Q9NPD5 | |
| IMTFLWNEKYGHKLD | 936 | P53804 | |
| ETFWKDSDMLACHNY | 241 | Q5R3I4 | |
| FQGFAVCVYHMADIW | 336 | Q9NS98 | |
| VCVYHMADIWEVFNG | 341 | Q9NS98 | |
| KCEQNLGHDTMYWYK | 41 | A0A576 | |
| WTDFEHMETIEKGYC | 546 | Q7Z2W4 | |
| DEQTCLMWAYEKGHD | 381 | Q59H18 | |
| KLFMSCLHAWGLNEV | 801 | Q9Y4E6 | |
| WMYQLQHGDQLSICF | 21 | Q8NA77 | |
| GHVVKCYWGKETLDM | 276 | P31483 | |
| GHMAKCYGDLVQELW | 781 | Q8NFA0 | |
| HGEILQVEEWKCMYA | 451 | P82987 | |
| INQMCYERALHWYAK | 111 | Q8TDW0 |